Does Type of Pancreaticojejunostomy after Pancreaticoduodenectomy Decrease Rate of Pancreatic Fistula? A Randomized, Prospective, Dual-institution Trial

被引:291
作者
Berger, Adam C. [1 ]
Howard, Thomas J. [3 ]
Kennedy, Eugene P. [1 ]
Sauter, Patricia K. [1 ]
Bower-Cherry, Maryanne [3 ]
Dutkevitch, Sarah [3 ]
Hyslop, Terry [2 ]
Schmidt, C. Max [3 ]
Rosato, Ernest L. [1 ]
Lavu, Harish [1 ]
Nakeeb, Atilla [3 ]
Pitt, Henry A. [3 ]
Lillemoe, Keith D. [3 ]
Yeo, Charles J. [1 ]
机构
[1] Thomas Jefferson Univ, Dept Surg, Jefferson Pancreas Biliary & Related Canc Ctr, Philadelphia, PA 19107 USA
[2] Thomas Jefferson Univ, Dept Pharmacol & Expt Therapeut, Jefferson Pancreas Biliary & Related Canc Ctr, Philadelphia, PA 19107 USA
[3] Indiana Univ, Dept Surg, Indianapolis, IN 46204 USA
关键词
DUCT-TO-MUCOSA; COMPLICATIONS;
D O I
10.1016/j.jamcollsurg.2008.12.031
中图分类号
R61 [外科手术学];
学科分类号
摘要
BACKGROUND: Pancreatic fistula (PF) is one of the most common complications after pancreaticoduodenectomy. There have been no large prospective randomized trials evaluating PF rates comparing invagination versus duct to mucosa pancreaticojejunostomy We tested the hypothesis that a duct to mucosa pancreaticojejunostomy would reduce the PF rate. STUDY DESIGN: Between August 2006 and May 2008, 197 patients at two institutions underwent pancreaticoduodenectomy by a total of 8 experienced pancreatic surgeons as part of this prospective randomized trial (clinical trial no. NCT00359320). All patients were stratified by pancreatic texture and randomized to either an invagination or a duct to mucosa pancreaticojejunal anastomosis. Recorded variables included pancreatic duct diameter, operative time, blood loss, complications, and pathology. Primary end point was PF rate,as defined by the International Study Group on Pancreatic Fistula. Secondary end points included PF grade, postoperative length of hospital stay, other morbidities, and mortality. RESULTS: Rate of PF for the entire cohort was 17.8%. There were 23 Fistulas (24%) in the duct to mucosa cohort and 12 fistulas (12%) in the invagination cohort (p < 0.05). The greatest risk factor for a PF was pancreas texture: PF developed in only 8 patients (8%) with hard glands, and in 27 patients (27%) with a soft gland. There were two perioperative deaths (both in the duct to mucosa group), with the proximate causes of death being PF, followed by bleeding and sepsis. CONCLUSIONS: This dual-institution prospective randomized trial reveals considerably fewer fistulas with invagination compared with duct to mucosa pancreaticojejunostomy after pancreaticoduodenectomy. Results confirm increased PF rates in soft as compared With hard glands. Additional studies are needed to define the optimal technique of pancreatic reconstruction after pancreaticoduodenectomy. (J Am Coll Surg 2009; 208:738-749. (C) 2009 by the American College of Surgeons)
引用
收藏
页码:738 / 747
页数:10
相关论文
共 19 条
  • [11] Conventional versus binding pancreaticojejunostomy after pancreaticoduodenectomy - A prospective randomized trial
    Peng, Shu You
    Wang, Jian Wei
    Cai, Xiu Jun
    Mou, Yi Ping
    Bin Liu, Ying
    Li, Jiang Tao
    [J]. ANNALS OF SURGERY, 2007, 245 (05) : 692 - 698
  • [12] Prospective trial of a blood supply-based technique of pancreaticojejunostomy: Effect on anastomotic failure in the Whipple procedure
    Strasberg, SM
    Drebin, JA
    Mokadam, NA
    Green, DW
    Jones, KL
    Ehlers, JP
    Linehan, D
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2002, 194 (06) : 746 - 758
  • [13] The evaluation of duct-to-mucosal pancreaticojejunostomy in pancreaticoduodenectomy
    Tani, M
    Onishi, H
    Kinoshita, H
    Kawai, M
    Ueno, M
    Hama, T
    Uchiyama, K
    Yamaue, H
    [J]. WORLD JOURNAL OF SURGERY, 2005, 29 (01) : 76 - 79
  • [14] THE COMPLICATIONS OF PANCREATECTOMY
    TREDE, M
    SCHWALL, G
    [J]. ANNALS OF SURGERY, 1988, 207 (01) : 39 - 47
  • [15] Does pancreatic duct stenting decrease the rate of pancreatic fistula following pancreaticoduodenectomy? Results of a prospective randomized trial
    Winter, Jordan M.
    Cameron, John L.
    Campbell, Kurtis A.
    Chang, David C.
    Riall, Taylor S.
    Schulick, Richard D.
    Choti, Michael A.
    Coleman, JoAnn
    Hodgin, Mary B.
    Sauter, Patricia K.
    Sonnenday, Christopher F.
    Wolfgang, Christopher J.
    Marohn, Michael R.
    Yeo, Charles J.
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2006, 10 (09) : 1280 - 1290
  • [16] Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s - Pathology, complications, and outcomes
    Yeo, CJ
    Cameron, JL
    Sohn, TA
    Lillemoe, KD
    Pitt, HA
    Talamini, MA
    Hruban, RH
    Ord, SE
    Sauter, PK
    Coleman, J
    Zahurak, ML
    Grochow, LB
    Abrams, RA
    [J]. ANNALS OF SURGERY, 1997, 226 (03) : 248 - 257
  • [17] YEO CJ, 1995, ANN SURG, V222, P580
  • [18] Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial
    Yeo, CJ
    Cameron, JL
    Lillemoe, KD
    Sauter, PK
    Coleman, J
    Sohn, TA
    Campbell, KA
    Choti, MA
    [J]. ANNALS OF SURGERY, 2000, 232 (03) : 419 - 426
  • [19] Z'graggen Kaspar, 2002, J Hepatobiliary Pancreat Surg, V9, P733